Results 191 to 200 of about 86,902 (236)
MFGM modulated gut microbiota accompanied by the increased serum RVD1 and AEA levels, which subsequently regulated the miRNA profile. This modulation alleviated neuroinflammation via suppressing the NLRP3 inflammasome signaling and microglial activation, thereby attenuating AD‐related cognitive impairment both in vivo and in vitro.
Han Gong +4 more
wiley +1 more source
GVO relieves constipation mechanisms. GVO decreased the abundance of Firmicutes and increased that of Bacteroidota, thereby ameliorating Lop‐induced gut microbial imbalances. Then the level of 8,9‐DiHETrE was raised, whereas the level of 15(S)‐HpETE was lowered.
Yanan Xu +11 more
wiley +1 more source
Medication-overuse headache overlapping with serotonin syndrome. [PDF]
Prakash S, Patel H, Shah CS.
europepmc +1 more source
Altered Mental Status in an Octogenarian: How Frequently Should Serotonin Syndrome Be Considered? [PDF]
Erdem S, Damlakhy A, Konja K, Bashar S.
europepmc +1 more source
Serotonin Syndrome Induced by Fentanyl Alone in an Adult Patient After Cardiac Surgery: A Case Report. [PDF]
Matsumura N +4 more
europepmc +1 more source
Potential Dextromethorphan-Induced Serotonin Syndrome Leading to Homicide and Suicide. [PDF]
Pavelka MM, Kohr R.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug and Therapeutics Bulletin, 2022
The serotonin syndrome is a life-threatening adverse drug reaction resulting from excess serotonergic agonism due to interactions between multiple drugs, poisoning, or less commonly due to therapeutic action of a single drug. The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular ...
Stuart Maitland, Mark Baker
+5 more sources
The serotonin syndrome is a life-threatening adverse drug reaction resulting from excess serotonergic agonism due to interactions between multiple drugs, poisoning, or less commonly due to therapeutic action of a single drug. The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular ...
Stuart Maitland, Mark Baker
+5 more sources
Critical Care Clinics, 1997
Serotonin syndrome is a potentially life-threatening complication of psychopharmacologic drug therapy. The syndrome is produced most often by the concurrent use of two or more drugs that increase brainstem serotonin activity and is often unrecognized because of the varied and nonspecific nature of its symptomatology. Serotonin syndrome is characterized
Ivanuša, Zrinka +2 more
openaire +5 more sources
Serotonin syndrome is a potentially life-threatening complication of psychopharmacologic drug therapy. The syndrome is produced most often by the concurrent use of two or more drugs that increase brainstem serotonin activity and is often unrecognized because of the varied and nonspecific nature of its symptomatology. Serotonin syndrome is characterized
Ivanuša, Zrinka +2 more
openaire +5 more sources
Neurology, 1995
We describe a patient treated with trazodone, isocarboxazid, and methylphenidate hydrochloride who developed confusion, agitation, poor concentration, rigidity, myoclonus, involuntary movements, orthostatic hypotension, and hyperreflexia. CK was normal, and the syndrome resolved spontaneously over 12 hours.
R A, Bodner, T, Lynch, L, Lewis, D, Kahn
openaire +2 more sources
We describe a patient treated with trazodone, isocarboxazid, and methylphenidate hydrochloride who developed confusion, agitation, poor concentration, rigidity, myoclonus, involuntary movements, orthostatic hypotension, and hyperreflexia. CK was normal, and the syndrome resolved spontaneously over 12 hours.
R A, Bodner, T, Lynch, L, Lewis, D, Kahn
openaire +2 more sources

